BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jing QD, A JD, Liu LX, Fan HN. Current status of drug therapy for alveolar echinococcosis. World J Hepatol 2024; 16(11): 1243-1254 [PMID: 39606163 DOI: 10.4254/wjh.v16.i11.1243]
URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1243.htm
Number Citing Articles
1
Zhuo-ma Dawa, Ting Zhai, Chuan-chuan Liu, Hai-ning Fan. Efficacy and safety of pseudolaric acid B against Echinococcus multilocularis in vitro and in a murine infection modelFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1503472
2
Efstathios T Pavlidis, Ioannis N Galanis, Theodoros E Pavlidis. Current considerations for the management of liver echinococcosisWorld Journal of Gastroenterology 2025; 31(10): 103973 doi: 10.3748/wjg.v31.i10.103973
3
Keisuke Sato, Naritaka Hikosaka, Hirokazu Kouguchi, Takao Irie, Masami Morimatsu, Takashi Agui. Narrowing the region of candidate genes that control the development of protoscoleces of Echinococcus multilocularis in the mouse liverInfection, Genetics and Evolution 2025; 127: 105704 doi: 10.1016/j.meegid.2024.105704
4
Nooshinmehr Soleymani, Soheil Sadr, Cinzia Santucciu, Abbas Rahdar, Giovanna Masala, Hassan Borji. Investigating the Therapeutic Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules in Hydatid Cyst-Infected MicePathogens 2025; 14(3): 240 doi: 10.3390/pathogens14030240